BioCentury
ARTICLE | Clinical News

Alista alprostadil: Phase IIb data

October 2, 2006 7:00 AM UTC

Data from the double-blind, placebo-controlled, U.S. Phase IIb trial in 320 women with FSAD, who have undergone hysterectomy, showed that Alista missed the primary endpoint of a significant improvemen...